Alliqua BioMedical, Inc. is developing a suite of advanced wound care solutions that will enable surgeons, clinicians, and wound care practitioners to address the entire spectrum of challenges presented by chronic and advanced wounds. Alliqua is building this portfolio through its proprietary hydrogel technology platform, targeted acquisitions, and through licensing and distribution agreements with strategic partners that include sorbion GmbH & Co. KG and Celgene Cellular Therapeutics, a subsidiary of Celgene Corporation. Alliqua's contract manufacturing business unit provides custom hydrogels to the OEM market. The Company is headquartered in Langhorne, PA.
Type
Public
HQ
Morrisville, US
Employees
87 (est)
Alliqua is headquartered in Morrisville, US

Key People at Alliqua

David Johnson

David Johnson

CEO, and Member of the Board of Directors
Brad C. Barton

Brad C. Barton

COO
Steven C. Berger

Steven C. Berger

Chief Financial Officer
Phillip Forman

Phillip Forman

Executive VP Clinical Affairs

Alliqua Locations

Morrisville, US

Alliqua Metrics

Alliqua Summary

Market capitalization

$17.2 M

Closing share price

$0.59
Alliqua's current market capitalization is $17.2 M.

Alliqua Financials

Alliqua's revenue is $15 M in FY, 2015 which is 214.26% increase from the previous period.
FY, 2013FY, 2014FY, 2015

Revenue

$1.8 M$4.79 M$15 M

Gross profit

$-299 K$1.52 M$8.99 M

Operating income

$-20.1 M$-25.4 M$-28.3 M

Operating expense total

$19.8 M$26.9 M$37.3 M

Net Income

$-22 M$-25.4 M$-26 M

Operating cash flow

$11.8 M$4.67 M$9.31 M

    Alliqua Market Value History

    We estimate that Alliqua's current employees are approximately 29% female and 71% male.

    Alliqua Online Presence

    Alliqua News

    Alliqua Company Life

    You may also be interested in